NCT03853733View on ClinicalTrials.gov

Hypofractionated Palliative Radiotherapy in Patients With Advanced Non-operable Rectal Cancer

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

October 1, 2016

Primary Completion Date

March 1, 2023

Study Completion Date

March 1, 2025

Conditions
Rectal Cancer
Interventions
RADIATION

rectal cancer radiotherapy

Conformal three-dimensional radiotherapy to deliver to the primary tumor and the enlarged pelvic nodes a total dose of 39Gy in 13 sessions of 3Gy in 17 days.

Trial Locations (1)

08227

RECRUITING

Consorci Sanitari de Terrassa, Terrassa

All Listed Sponsors
lead

Consorci Sanitari de Terrassa

OTHER

NCT03853733 - Hypofractionated Palliative Radiotherapy in Patients With Advanced Non-operable Rectal Cancer | Biotech Hunter | Biotech Hunter